Amazon GLP-1 therapy
Supply: Amazon Inc.
Amazon is pushing deeper into the booming weight reduction market, unveiling Tuesday a brand new program that goals to simplify entry to in style GLP-1 remedies.
The corporate stated its major care arm, Amazon One Medical, is launching a GLP-1 administration program that integrates weight problems therapy into routine care. The providing combines digital and in-person visits, prescription administration and pharmacy success, positioning weight administration as a long-term power situation relatively than a one-off prescription.
“Offering prospects with quick, handy medicine entry and clear, clear pricing is integral to how Amazon Pharmacy is remodeling the pharmacy expertise,” stated Tanvi Patel, vice chairman and basic supervisor of Amazon Pharmacy, within the firm’s press launch.
“By increasing entry to the newest GLP-1 medicines with upfront, clear pricing, we’re making it simpler for purchasers to get the remedies their well being care suppliers prescribe and to remain on these medicines as a result of they’re delivered reliably on to sufferers,” Patel stated.
By Amazon Pharmacy, sufferers will be capable of entry medicines together with Novo Nordisk’s Wegovy in addition to newer oral GLP-1 choices. Insured pricing will begin as little as $25 per 30 days, Amazon stated. For cash-paying sufferers, oral medicine begin at $149 per 30 days, it stated.
Injectable remedies, together with Wegovy pictures and Eli Lilly’s Zepbound, start at $299 per 30 days when paid for with out insurance coverage, Amazon stated.
These costs are roughly in keeping with a lot of the present market.
However Amazon’s edge is in same-day supply and comfort because it seems to be to leverage its logistics community and client attain into one other nook of the medical system.
The corporate additionally stated it is going to provide on-demand prescription renewals, beginning at $29 for message session and $49 for video care. Amazon plans to develop its same-day drug supply providing to 4,500 cities by the tip of 2026.
Shares of a number of corporations tied to the weight problems drug growth moved decrease following Amazon’s Tuesday announcement, together with Hims & Hers Well being, Viking Therapeutics, Amgen and Septerna.